BrightGene Bio-Medical Technology Co., Ltd. (688166)

Overview

BrightGene Bio-Medical Technology Co., Ltd., founded in 2001 and based in Suzhou, China, is a prominent pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of pharmaceutical products within the Chinese market. The company’s activities span a range of medical fields, including antitumor, anti-infection, cardiovascular, cerebrovascular, and more, showcasing its commitment to improving healthcare outcomes through innovative pharmaceutical solutions.

Products and Services

• Eribulin Mesylate Injection

  Utilized in cancer treatment, especially for patients with metastatic breast cancer, demonstrating BrightGene’s focus on antitumor medication.

• Voriconazole for Injection

  An antifungal medication designed for severe fungal infections, underlining the company’s dedication to combating infectious diseases.

• Entecavir Tablets

  A potent antiviral drug used in the treatment of hepatitis B infection, showcasing the company’s efforts in managing viral diseases.

• Oseltamivir Phosphate Capsule and Dry Suspension

  Targeted for the treatment and prevention of influenza, reflecting BrightGene’s commitment to addressing seasonal and pandemic flu outbreaks.

• Agatroban Injection

  A direct thrombin inhibitor used in cases of heparin-induced thrombocytopenia, indicating the company’s involvement in cardiovascular medicine.

• Mikafungin Sodium for Injection

  An echinocandin antifungal used to treat fungal infections, another example of BrightGene’s anti-infection product line.

• Fondaparinux Sodium Injection

  An anticoagulant used to prevent deep vein thrombosis (DVT), aligning with the company’s cardiovascular health solutions.

• Caspofungin Acetate for Injection

  Part of the echinocandin class, this is used to treat fungal infections, further emphasizing BrightGene’s strength in anti-infection medication.

In addition to these specific pharmaceutical products, BrightGene also develops and provides a variety of APIs (Active Pharmaceutical Ingredients) and intermediates for antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other medical fields. Moreover, the company extends its healthcare contributions to veterinary medicine, indicating a broad spectrum of pharmaceutical expertise and services designed to improve health outcomes across a wide range of patient needs.